These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2855896)

  • 1. Reconstitution of defective phagocyte function in chronic granulomatous disease of childhood with recombinant human interferon-gamma.
    Gallin JI; Sechler JM; Malech HL
    Trans Assoc Am Physicians; 1988; 101():12-7. PubMed ID: 2855896
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.
    Ezekowitz RA; Dinauer MC; Jaffe HS; Orkin SH; Newburger PE
    N Engl J Med; 1988 Jul; 319(3):146-51. PubMed ID: 2838754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.
    Sechler JM; Malech HL; White CJ; Gallin JI
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4874-8. PubMed ID: 2838849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferon gamma for treatment of chronic granulomatous disease and other disorders.
    Bolinger AM; Taeubel MA
    Clin Pharm; 1992 Oct; 11(10):834-50; quiz 892-4. PubMed ID: 1341990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological and clinical aspects of chronic granulomatous disease].
    Robak T; Robak E
    Przegl Lek; 1992; 49(5):168-71. PubMed ID: 1438921
    [No Abstract]   [Full Text] [Related]  

  • 6. Phagocytes use oxygen to kill bacteria.
    Baggiolini M
    Experientia; 1984 Sep; 40(9):906-9. PubMed ID: 6088281
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic granulomatous disease (CGD): in vitro enhancement of bactericidal activity of CGD phagocytes by rifampicin].
    Samson J; Lapointe N
    Ann Immunol (Paris); 1977; 128(1-2):75-6. PubMed ID: 848909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of children on interferon therapy.
    Vitale MK; Willwerth-Fortin J; Robbins K
    Pediatr Nurs; 1993; 19(3):230-4. PubMed ID: 8511002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.
    Weening RS; Corbeel L; de Boer M; Lutter R; van Zwieten R; Hamers MN; Roos D
    J Clin Invest; 1985 Mar; 75(3):915-20. PubMed ID: 3980731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetic measurement of phagocyte function in whole blood.
    Boghossian SH; Wright G; Segal AW
    J Immunol Methods; 1983 May; 60(1-2):125-40. PubMed ID: 6854026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic granulomatous disease and other disorders of phagocyte function.
    Dinauer MC
    Hematology Am Soc Hematol Educ Program; 2005; ():89-95. PubMed ID: 16304364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemoluminescence of the human neutrophilic granulocyte, II. Origin, normal values, hereditary deficiencies].
    Dragomirescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1985; 30(3):193-222. PubMed ID: 2996111
    [No Abstract]   [Full Text] [Related]  

  • 13. [Defective abilities of phagocytes in chronic granulomatous disease (author's transl)].
    Kobayashi Y
    Rinsho Ketsueki; 1978 Jul; 19(7):897-903. PubMed ID: 702824
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic granulomatous disease. Clinical symptoms and biochemical background].
    Weening RS; Kollee LA; van Gool JD; Roos D
    Ned Tijdschr Geneeskd; 1976 Aug; 120(35):1480-7. PubMed ID: 184401
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on chronic granulomatous disease: the concept of the near-normal host.
    Ezekowitz RA
    Curr Clin Top Infect Dis; 2000; 20():325-34. PubMed ID: 10943531
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experiences with interferon-alpha and interferon-gamma.
    Steinmann GG; Rosenkaimer F; Leitz G
    Int Rev Exp Pathol; 1993; 34 Pt B():193-207. PubMed ID: 8458713
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug approval: product licensing by phone.
    Buderi R
    Nature; 1990 Jan; 343(6255):196. PubMed ID: 2105468
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease.
    Saulsbury FT
    Clin Infect Dis; 2001 May; 32(10):E137-9. PubMed ID: 11317265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic granulomatous disease: newly defined molecular abnormalities explain disease variability and normal phagocyte physiology.
    Forehand JR; Johnston RB
    Curr Opin Pediatr; 1994 Dec; 6(6):668-75. PubMed ID: 7849812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI
    Int J Tissue React; 1993; 15(3):99-103. PubMed ID: 8188451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.